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1. Introduction 13 
Polysaccharides have been used traditionally by the food industry for their viscosifying, 14 
emulsifying and biothickening properties and more recently for manufacture of functional 15 
food due to their prebiotic and immunomodulating properties. 16 
Bacteria can synthesize cytoplasmic storage polysaccharides (e.g. glycogen), cell wall 17 
structural polysaccharides such as peptidoglycan, and lipoteichoic acids of gram-positive 18 
bacteria, and the lipopolysaccharides anchored in the outer membrane of gram-negative 19 
bacteria. In addition, some bacteria can secrete polysaccharide layers on their surface, which 20 
together with a few glycoproteins, constitute the glycocalyx. These exocellular polymers 21 
comprise the capsular polysaccharides, which form a cohesive layer or capsule covalently 22 
linked to the cell surface, and the exopolysaccharides (EPS), which form a slime layer 23 
loosely attached to the cell surface or secreted into the environment (Brock, 2008). The 24 
physiological role of these molecules are not yet clearly understood, although it is generally 25 
recognized that exocellular polysaccharides are not normally used as energy and carbon 26 
sources by the producing microorganism. They can serve for a variety of functions including 27 
cell recognition and interaction, adherence to surfaces and biofilm formation. 28 
The majority of the polysaccharides used as additives by the food industry such as pectin, 29 
cellulose and alginate are obtained from plants and algae. However, other biopolymers like 30 
xanthan and gellan, also used as bio-thickeners, are synthesized by gram-negative bacteria. 31 
Furthermore, lactic acid bacteria (LAB) producing EPS are used mainly in the dairy industry 32 
for improvement of the rheological properties of fermented products as well as for the 33 
manufacture of functional food.  34 
The taste/texture benefits of the EPS produced by LAB in fermented foods are well 35 
established, because these organisms produce polymers that improve the rheological 36 
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properties of dairy product. When they are added to food, polysaccharides show functions 1 
as thickeners, stabilizers, emulsifiers, gelling agents, and water binding agents (Kimmel et 2 
al., 1998). They also contribute to preservation, and enhance the organoleptic characteristics 3 
of milk and dairy products such as flavour and aroma (Macedo et al., 2002). More recently, 4 
these bio-molecules have been regarded as health promoters due to their role as prebiotics 5 
and/or the immunomodulatory properties linked to their structure. As a result, a number of 6 
studies are in progress in order to characterize the unmapped diversity of the EPS produced 7 
by LAB, since they are considered food-grade organisms. 8 
In this chapter, we shall review the current knowledge pertaining to the EPS synthesized by 9 
LAB, from biogenesis to application, detailing their nature and structure. Moreover, the 10 
methods most frequently used for the production and purification of these biopolymers will 11 
be presented. 12 
2. Composition, structure and classification of EPS 13 
The EPS synthesized by LAB vary greatly in their chemical composition, structure and 14 
molecular weight. According to their chemical composition, EPS are classified into 15 
heteropolysaccharides (HePS) and homopolysaccharides (HoPS). 16 
HePS are constructed of a backbone of repeated subunits that are linear or branched, with 17 
variable molecular masses (up to 106 Da). Each one of these subunits can contain between 18 
three and eight different monosaccharides and frequently has a range of different linkage 19 
patterns. The monosaccharides are present as the α- or β-anomer in the pyranose or 20 
furanose form and D-glucose, D-galactose and L-rhamnose are the most frequently 21 
encountered. In few cases, N-acetylglucosamine, N-acetylglucosamine, manose, fucose, 22 
glucuronic acid and non-carbohydrate substituents (phosphate, acetyl and glycerol) are also 23 
present (de Vuyst & Degeest, 1999; de Vuyst et al., 2001). 24 
Different strains of LAB isolated from dairy products, cereals and alcoholic beverages 25 
synthesize HePS. These belong to the genera Lactococcus (L. lactis subsp. cremoris, L. lactis 26 
subsp lactis), Lactobacillus (Lb. acidophilus, Lb. delbrueckii subsp. bulgaricus, Lb. casei, Lb. sakei, 27 
Lb. rhamnosus Lb. helveticus), Streptococcus (S. thermophilus, S. macedonicus) and Leuconostoc 28 
(Lc. mesenteroides) (Montersino et al., 2008; Mozzi et al., 2006; Van der Meulen et al., 2007). 29 
HoPS are composed of repeated units that contain only one type of monosaccharide: D-30 
glucopyranose (glucans) or D-fructopyranose (fructans). These polysaccharides usually 31 
display high molecular masses (up to 107 Da), and have different degrees and types of 32 
branching, linking sites and chain length. Based on their structure, the fructans can be 33 
divided into two groups: (i) inulins (linked  β-2,1) and (ii) levans (linked β-2, 6), both are 34 
synthesized by different species of the genera Leuconostoc, Lactobacillus, Streptococcus and 35 
Weissella.  36 
Glucans can be classified into α- and β-D-glucans. The former are more widely found in 37 
LAB and they are produced by strains belonging to the genera Lactobacillus, Leuconostoc and 38 
Streptococcus. According to the linkages in the main chain, the α-glucans are subdivided into 39 
dextrans (α-1,6), mutans (α-1,3), glucans (α-1,2), reuterans (α-1,4) and alternans (α-1,3 and 40 
α-1,6) (Figure 1). These polymers may have side-chain branches that involve others α-41 
linkages different from the main chain. For example, the dextrans produced by various LAB 42 
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such as Leuconostoc mesenteriodes and Lactobacilli, may have branches with α-1,2, α-1,3 or α-1 
1,4 linkages. The dextran most widely used by the industry is a polysaccharide containing 2 
95% α-1,6 and 5% α-1,3 linkages synthesized by Lc. mesenteroides NRLL BF512 (Korakli & 3 
Vogel, 2006; Monsan et al., 2001; van Hijum et al., 2006).  4 
 5 
Fig. 1. Schematic representation of the repeating units of: dextran, mutan, alternan, glucan 6 
and reuteran (Korakli & Vogel, 2006) 7 
(1,3) β-glucans are found in bacteria and eukaryotic organisms. These polysaccharides 8 
include the linear glucans and 6-substituted (1,3) β-glucans that have branch-on-branch or 9 
cyclic structures. Concerning prokaryotes, several bacteria including Agrobacterium and 10 
Rhyzobium species can produce these polymers. One such structure, curdlan, has been 11 
approved as a food additive by the Food and Drug Administration (FDA), and essentially is 12 
a linear (1,3) β-D-glucan which may have a few inter- or intra- chain (1,6) linkages (McIntosh 13 
et al., 2005). 14 
β-glucan production is rarely found in LAB. It has only been reported to be synthesized and 15 
secreted by a small number of strains isolated from alcoholic beverages, namely: Pediococcus 16 
parvulus IOEB8801 and Oenococcus oeni IOEB0205 from wine and P. parvulus 2.6R, CUPV1, 17 
CUPV22, Lb. diolivorans G77 and O. oeni I4 from cider (Dueñas-Chasco et al., 1997, 1998; 18 
Garai-Ibabe et al., 2010; Ibarburu et al., 2007; Llauberes et al., 1990). 19 
In all cases, these β-D-glucans have a common structure comprising a main chain of (1,3)-20 
linked β-D-glucopyranosyl units along with more or less frequent side chains of β-D-21 
glucopyranosyl units attached by (1,2) linkages (Figure 2).  22 
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  1 
Fig. 2. Schematic representation of the repeating unit of  β-(1,3-1,2)-D-glucan of P. parvulus 2 
2.6 (Dueñas-Chasco et al., 1997) 3 
In addition, a similar polymer constitutes the capsule of S. pneumoniae serotype 37 and the 4 
EPS secreted by Propionibacterium freundenreichii subsp. shermanii TL34 (Adeyeye et al., 1988; 5 
Nordmark et al., 2005).  6 
3. Biosynthesis of EPS 7 
3.1 Genetic determinants and mechanisms of production and secretion 8 
The genes involved in the biogenesis of the HePS are usually organized in clusters that can 9 
be located either in the chromosome of the thermophilic LAB (e. g. S. thermophilus Sfi6) or in 10 
plasmids of mesophilic bacteria (e.g. L. lactis subsp. cremoris NIZO B40) (Laws et al., 2001). 11 
This structural organization is highly conserved among LAB and is very similar to that 12 
observed for the operons and clusters involved in the synthesis of: (i) O-antigen 13 
lipopolysaccharides in enterobacteria, (ii) capsules (CPS) of pathogens, such as S. pneumoniae 14 
or Staphylococcus aureus and (iii) the EPS from Sinorhizobium meliloti (García et al., 2000; 15 
Glucksmann et al., 1993; Lin et al., 1994). 16 
The clusters from LAB have been reported for S. thermophilus, Lb. helveticus, L. lactis, Lb. 17 
delbrueckii subsp. bulgaricus, Lb. rhamnosus and the Lb. casei group (Ruas-Madiedo et al, 2008). 18 
The genes are oriented in a single direction and transcribed as a single mRNA. The genes 19 
are grouped into four regions within the cluster: The first contains genes whose products are 20 
regulatory proteins; the second includes genes encoding proteins involved in 21 
polymerization/chain length determination; the third contains genes encoding enzymes 22 
required for the biosynthesis of the HePS repeating units, and the genes of the last region 23 
encode proteins implicated in transport and polymerization (Figure 3) (Jolly & Stingele, 24 
2001). 25 
Additionally, these clusters may occasionally include genes involved in biosynthesis of 26 
nucleotide sugars from which the repeating units are constructed. Thus, in Lb. rhamnosus, 27 
they are associated to the EPS operon and they can be transcribed either from their own 28 
promoter or together with the EPS operon genes (Péant et al., 2005). There is a great 29 
variability in the genes involved in the synthesis of the repeating units. This region is 30 
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responsible for the production of a specific EPS type; whereas the genes of polymerization 1 
and transport are more conserved. 2 
 3 
Fig. 3. Organization of the eps gene clusters of (A) S. thermophilus Sfi6 (B), L. lactis subsp. 4 
cremoris NIZO B40 and (C) Lb. bulgaricus Lfi5 (Lamothe et al., 2002; Laws et al., 2001). The 5 
proposed function of the different gene products is indicated 6 
HePS are made by the polymerization of repeating unit precursors formed in the cytoplasm. 7 
They are assembled at the membrane by the sequential addition of nucleotides sugars (e.g., 8 
UDP-glucose, UDP-galactose and dTDP-rhamnose) or nucleoside diphosphate sugars to the 9 
growing repeated units through the action of the specific glycosyltransferases. This unit is 10 
most probably anchored to a lipid carrier molecule located in the plasma membrane and the 11 
first monosaccharide is linked by the action of a type of glycosyltransferase called priming-12 
glycosyltransferase. It has been proposed that this lipid carrier might be an isoprenoid 13 
derivative such as undecaprenyl-phosphate (C55-P) by analogy with the synthesis of other 14 
EPS of gram-negative bacteria, as well as in the assembly of peptidoglycan, lipoteichoic 15 
acids and O-antigen lipopolysaccharides (Ruas-Madiedo et al., 2009). However some studies 16 
based in the resistance to bacitracin (a compound that blocks the transformation of the C55-17 
PP to C55-P), suggested that HePS biosynthesis in S. thermophilus Sfi6 uses a lipid carrier 18 
different from undecaprenyl carrier (Stingele et al., 1999).  19 
The mechanisms of polymerization, chain length determination and export still remain 20 
poorly understood. However, the similarity of gene products involved in these processes to 21 
those participating in the polymerization and export of O-antigens from Escherichia coli and 22 
the EPS of S. meliloti, suggests that probably LAB utilize similar mechanisms for 23 
polymerization and export of EPS. Thus, an enzyme of the flipase family could transfer the 24 
lipid-bound repeating units from the cytoplasmic face of the membrane to the external face. 25 
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Using the same line of argument, a polymerase could catalyze the linking of the repeating 1 
units and an enzyme could uncouple the lipid-bound polymer and control chain length 2 
(Laws et al., 2001). 3 
The regulatory mechanisms involved in expression of the HePS genes remain unclear. 4 
However, a transcriptional regulatory role has been proposed for a group of gene products 5 
in different LAB genera, due to their similarity with a family of transcriptional regulators 6 
whose prototype is LytR, the regulator of the autolysin operon of Bacillus subtilis (Ruas-7 
Madiedo et al., 2009). 8 
Finally, a variety of nucleotide sugars is needed for the synthesis of a range of 9 
polysaccharides which is not specific to EPS biosynthesis. The production of these 10 
precursors occurs in the cytoplasm, mainly from glucose 1-P which is synthesized from 11 
glucose 6-P. These two forms of phosphorylated glucose are part of the central metabolism 12 
of the bacterium, which begins with the transport of sugar to the interior of the cell (de 13 
Vuyst et al., 2001). 14 
Concerning to HoPS, most of them ( α-glucans and fructans) are synthesized from sucrose 15 
through the action of extracellular enzymes commonly named glycansucrases. Enzymes 16 
synthesizing α-glucan polymers are limited to LAB, while enzymes synthesizing fructans, 17 
are present in other gram-positive and gram-negative bacteria. A large number of these 18 
glycansucrase encoding genes have been identified in the chromosomes of Streptococcus, 19 
Leuconostoc and Lactobacillus strains and they usually form part of a monocistronic 20 
transcriptional unit. Some of these genes are expressed constitutively whilst other are 21 
sucrose-inducible (Gänzle & Schwab, 2009; van Hijum et al., 2006).  22 
Only one gene, named gtf, is required for the α-glucan biosynthesis in LAB. This gene is 23 
located in a 35 kb plasmid of P. parvulus 2.6 or in a 5.5 kb plasmid of P. parvulus IOEB8801, 24 
CUPV1, CUPV22, Lb. diolivorans G77 and Lb. suebicus CUPV221, while gtf is located in the 25 
chromosome of Oenococcus oeni I4 and IOEB0205 (Dols-Lafargue et al., 2008; Garai-Ibabe et 26 
al., 2010, Walling et al., 2001; Werning et al, 2006). All of these bacteria produced the same 27 
2-substitute (1,3)-β-D-glucan and their gtf genes show high level of homology (at least 28 
97%). 29 
The gtf gene encodes a β-glycosyltransferase (GTF). It is a membrane protein whose 30 
topological prediction indicates that β-glucan or, at least its repeating unit precursors, are 31 
synthesized in the cytosol (Werning et al., 2006). In agreement, in vitro experiments indicate 32 
that the β-glucan polymer is synthesized by GTF directly from UDP-glucose (Werning et al., 33 
2008) which, as mentioned above, is part of the central metabolism of the bacterium and is 34 
available within the cell. The translocation through the membrane is performed by a 35 
mechanism that is not yet known. The fact that heterologous expression of GTF in other 36 
LAB leads to the synthesis and secretion of β-glucan in the recipient bacteria, strongly 37 
suggests that this polymer does not require specific transporters to be released into the 38 
extracellular space (Stack et al., 2010; Werning et al., 2008). Supporting this hypothesis, the 39 
capsular 2-substituted (1,3)-β-glucan of S. pneumoniae serotype 37, is synthesized by a single 40 
β-glycosyltransferase called Tts (which shares a 33% identity with GTF), and its 41 
heterologous expression in other gram-positive bacteria, also result in the capsular EPS 42 
formation (Llull et al., 2001).  43 
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The presence of four potential transmembrane regions at the C-terminal region of GTF 1 
glycosyltransferase and two more at its N-terminus suggest the formation of a membrane 2 
pore by the enzyme to facilitate the extrusion of the polymer (Werning et al., 2006). In this 3 
regard, there is experimental evidence (Heldermon et al., 2001; Tlapak-Simons et al., 1998, 4 
1999) suggesting that in the HAS glycosyltransferase from S. pyogenes only four 5 
transmembrane domains and two membrane-associated regions are sufficient to interact 6 
with the membrane phospholipids and to create a pore-like structure through which a 7 
nascent hyaluronan chain can be extruded to the exocellular environment. A similar 8 
mechanism could happen in the translocation of curdlan through the Agrobacterium 9 
membrane, for which it has been proposed that a pore could be formed by interaction of the 10 
CrdS synthase with phosphatidylethanolamine (Karnezis et al., 2003). Thus, the association 11 
of several GTF monomers could form a pore for extrusion of the EPS and, that might 12 
promote the processive catalysis of GTF carried out by this enzyme. However other 13 
alternative mechanisms might allow the translocation or secretion of β-glucan across LAB 14 
membranes. This includes the use of an ABC-like transporter, since this class of transporter 15 
can export various bacterial polysaccharides (Silver et al., 2001). 16 
Finally, it should be noted that the presence of mobile genetic elements is a common feature 17 
in the genetic organization of the DNA region involved in HePS or HoPS synthesis 18 
(Bourgoin et al., 1999; Dabour & LaPointe, 2005; Peant et al., 2005; Tieking et al., 2005; van 19 
Hijum et al., 2004). It is well known that these elements allow horizontal transfer between 20 
different genera. In this regard, its presence could explain the instability of the HePS-21 
producer phenotype of some strains (Ruas-Madiedo et al., 2009) as well as the loss of 22 
expression of some glycansucrases or the presence of chimeras in different HoPS-producing 23 
strains (Gänzle & Schwab, 2009). The gtf genes of LAB are flanked by genes which could be 24 
involved in functions of conjugation and recombination, respectively (Werning et al., 2006; 25 
Dols-Lafargue et al., 2008). Thus, horizontal transfer mediated by plasmids or transposition 26 
events, might explain the wide distribution and high degree of gtf gene preservation in β-27 
glucan-producing strains belonging to different genera. 28 
3.2 Enzymes for production. 29 
HePS and β-glucans are produced by glycosyltransferases which use sugar nucleotides as 30 
substrate. On the other hand,  α-glucans and fructans are synthesized by glycansucrases 31 
which are able to use the energy of the glycosidic bond of sucrose to ligate glucose or 32 
fructose to the growing polysaccharide chain. In addition, these enzymes can synthesize 33 
hetero-oligosaccharides, when the acceptors are maltose and isomaltose (Monsan et al., 34 
2001). 35 
Enzymes synthesizing α-glucan polymers are called glucansucrases (GS) and those 36 
synthesizing fructans are named fructansucrases (FS). Unlike the glycosyltransferases 37 
(discussed below), GS and FS are transglycosidases evolutionarily, structurally, and 38 
mechanistically related to the glycosyl-hydrolases (GH). Therefore, according to the 39 
classification of the GH into families (which is based on the amino acid sequences) GS and 40 
FS can be respectively placed within the GH70 and the GH68 families (Henrissat & Bairoch, 41 
1996). In addition, according to the Nomenclature Committee of the International Union of 42 
Biochemistry and Molecular Biology (UIBMB), GS enzymes are classified (according to the 43 
reaction they catalyze and the type of product) into: (i) dextransucrases (E.C.2.4.1.5) and (ii) 44 
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alternansucrases (E.C.2.4.1.140). The mutansucrases and reuteransucrases are classified 1 
together with the dextransucrase enzymes. Also, FS enzymes can be classified, based on the 2 
different products synthesized, into: (i) inulosucrases (E.C.2.4.1.9) and ( ii) levansucrases 3 
(E.C.2.4.1.10) (van Hijum et al., 2006). 4 
Although GS and FS enzymes perform very similar reactions on the same substrate, they do 5 
not show great similarities in their amino acid sequence and strongly differ in their protein 6 
structures. Regarding the amino acid sequence, these enzymes are composed of 4 structural 7 
domains from the N to the C terminus: (i) a signal peptide involved in the secretion of the 8 
enzyme; (ii) a variable N-terminal domain of unknown function; (iii) a conserved catalytic 9 
domain comprising sucrose-binding and sucrose-cleaving domain and in FS also a calcium 10 
ion binding site and (iv) a C-terminal domain, that is composed of a series of tandem repeats 11 
which is thought to be involved in the control of product size as well as in α-glucan binding 12 
(GS), or in cell wall anchoring (FS) (Korakli & Vogel, 2006). 13 
The mechanism of action of GS has still not fully understood. The key step in the transfer of 14 
D-glucosyl units is the formation of a covalent glucosyl-enzyme intermediate, in which an 15 
amino acid triad, composed of two aspartate and one glutamate residues, is involved. From 16 
this intermediate, the glucosyl unit is transferred to the acceptor (the polymer in growth) by 17 
a processive catalytic mechanism. The overall synthesis can be described as three steps: 18 
initiation, elongation and termination. The last corresponds to the dissociation of the α-19 
glucan-enzyme complex. Regarding the elongation, this can proceed by two alternative 20 
mechanisms, one acts at the reducing end and the other at the non-reducing end of the 21 
growing α-glucan chain (Monchois et al., 1999; Monsan et al., 2001). 22 
So far little is known about the mechanism of action of the FS enzymes. Fructan biosynthesis 23 
could be carried out by a multiple elongation mechanism, where the fructose residues are 24 
added to the growing fructan chain. The catalytic mechanism proposed for the 25 
transfructosylation reaction occurs in two steps, involving both a nucleophilic and an 26 
acidophilic site, through the formation of a covalently linked intermediary fructosyl-enzyme 27 
( Monsan et al., 2001; Sinnott, 1991). 28 
The glycosyltransferases are ubiquitous enzymes in prokaryotes and eukaryotes. They are 29 
involved in the biosynthesis of oligosaccharides, polysaccharides and glyconjugates (e.g. 30 
lipopolysaccharides and glycoproteins). These enzymes are responsible for the biosynthesis 31 
of glycosidic bonds by the transfer of a sugar residue from activated donor molecules to 32 
specific acceptor molecules. Donor sugar substrates are mostly nucleotide sugars; however 33 
they can also be nucleoside monophosphate sugars, lipid phosphate sugars and sugar 1-34 
phosphate. Frequently the acceptors are other sugars but they can be lipids, nucleic acids, 35 
antibiotics, etc. Additionally, two stereochemical outcomes are possible for reactions that 36 
result in the formation of a new glycosidic bond: the anomeric configuration of the product 37 
can be retained (α-glycosyltransferases) or inverted (β-glycosyltransferases) with respect to 38 
the donor substrate (Lairson et al., 2008).  39 
The HePS biosynthesis in LAB involves several enzymes for production of repeating units: a 40 
priming-glycosyltransferase that transfers the first sugar from sugar 1-phosphate onto a 41 
phosphorylated carrier lipid and one or more α- or β-glycosyltransferases that sequentially 42 
add new sugars from nucleotide sugars to the growing repeating unit. Some already 43 
characterized examples of these enzymes are: EpsE, a phospho-galactosyltransferase from S. 44 
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thermophilus Sfi6 and EpsD a phospho-glucosyltransferase from L. lactis subsp. cremoris B40, 1 
which are priming-glycosyltransferases. Examples of other glycosyltransferases are: EpsG, 2 
an N-acetyl-glucosaminetransferase from S. thermophilus Sfi6, which transfers N-3 
acetylglucosamine to a β-galactose precursor anchored to a carrier lipid or EpsG, that 4 
catalyzes the linkage of galactose to a cellobiose precursor anchored to a carrier lipid from L 5 
lactis subsp. cremoris (Ruas-Madiedo et al., 2009). 6 
As mentioned above, the 2-substituted (1,3)-β-D-glucan biosynthesis of P. parvulus 2.6 is 7 
carried out by the GTF glucosyltransferase. GTF was overproduced in L. lactis NZ9000 and 8 
purified as a membrane-associated enzyme (Werning et al., 2008). These membrane 9 
preparations used UDP-glucose as donor substrate to catalyze the biosynthesis of a high 10 
molecular weight polysaccharide that corresponds to the 2-substituted (1,3)-β-D-glucan 11 
(Werning et al., 2008 and unpublished results). The acceptor is so far unknown, but it could 12 
be the growing β-glucan polymer or any lipid molecule present in the cellular membranes.  13 
Traditionally, glycosyltransferases have been classified on the basis of their donor, acceptor 14 
and product specificity according to the recommendations of the IUBMB. However, this 15 
system requires full characterization before an Enzyme Commission (EC) number can be 16 
assigned. To overcome this limitation, these enzymes have been classified into families on 17 
the basis of amino acid sequence similarities as in the case of GH. At present there are 18 
already 91 families (referred to as GTx), available at URL: 19 
http://www.cazy.org/fam/acc_GT.html. This classification is periodically reviewed and 20 
updated (Coutinho et al., 2003). 21 
According to protein sequence similarity, enzymes that produce HePS can be grouped into 22 
various families. With regard to HoPS, the dextransucrases have been included in the family 23 
of glycosyl hydrolases GH70. In addition, GTF belongs to the GT-2 family that includes 24 
other glycosyltransferases such as cellulose syntheses, β-1,3 glucan synthases, 25 
chitinsynthases, HAS and β-glucosyltransferases. All of these enzymes have in common that 26 
they use a nucleotide sugar as substrate for the synthesis of a polymer, with inversion of 27 
anomeric configuration of the donor substrate. 28 
Two general three-dimensional (3D) folding models, called GT-A and GT-B have been 29 
observed for all the structures of nucleotide-sugar-dependent glycosyltransferases solved to 30 
date, and two mechanisms for retaining or inverting enzymes can be proposed within both 31 
classes. The GT-A fold may be considered as two tightly associated and abutting β/α/β 32 
Rossmann domains that tend to form a continuous central sheet of at least eight β-strands. 33 
The GT-B fold consists of two β/α/β Rossmann domains that face each other and are linked 34 
flexibly. These domains correspond to the donor substrate and acceptor binding sites 35 
(Breton et al., 2005; Lairson et al., 2008). 36 
So far, no 3D-structure has been resolved for any glycosyltransferase involved in EPS 37 
synthesis from LAB, which would be essential for a better understanding of the mode of 38 
action of these enzymes. However, using the GT classification system proposed by Coutinho 39 
et al (2003) (in which families can be classified into clans on the basis of their folding and 40 
stereochemical outcome of the reaction that they catalyze) it is possible to predict that the 41 
glycosyltransferases can adopt one of two possible foldings. Thus, GTF from P. parvulus 2.6 42 
belongs to the inverting-clan I of GT-A glycosyltransferases. A 3D-dimensional model based 43 
on the sequence of the putative active domain of GTF was built using as template the 44 
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experimentally resolved structures of SpsA synthase from Bacillus subtilis (PDB code 1qgq) 1 
and of a putative glycosyltransferase from Bacteroides fragilis (PDB code 3bcv). The model 2 
proposed for GTF corresponds to a GT-A fold, which consist of an open twisted β-sheet 3 
surrounded by α-helices on both sides, where the N- and C-terminus domains are 4 
respectively the donor substrate and the acceptor binding sites (Figure 4). 5 
 6 
                                               (A)                                                                                    (B) 7 
Fig. 4. Three-dimensional model for the putative active site of GTF constructed using resolved 8 
structures of SpsA from B. subtilis (A) and a putative glycosyltransferase from Bc. fragilis (B). 9 
The conserved N-terminal nucleotide-binding domain is shown in green and the C-terminal 10 
acceptor domain in red. The ball-and-stick representations show putative residues involved 11 
in the catalytic center: D143, D198 and D200 at the N-terminal domain and D306 at the C-12 
terminal domain (in blue) as well as D295 (in violet), which is an alternative residue to D306, 13 
whose putative functions are discussed in the text 14 
Based on structural data and on site directed mutagenesis experiments, it has been proposed 15 
that only four aspartic or carboxylate groups are required to form a single catalytic center of 16 
GT-A inverting enzymes (Charnock et al., 2001; Garinot-Schneider et al., 2000; Keenleyside 17 
et al., 2001; Tarbouriech et al., 2001). Three Asp located at the N-terminus domain are 18 
involved in nucleoside diphosphate (NDP) coordination. The first Asp residue is implicated 19 
in the recognition of uracil or thymine base. The other two, commonly referred to as DXD 20 
motif, bind to hydroxyl groups on the ribose moiety and the divalent metal ion (Mg2+ or 21 
Mn2+), which in turn coordinate the phosphate groups from NDP, facilitating the release of 22 
the NDP from the donor substrate. A fourth residue, Asp or Glu, in the acceptor domain (C-23 
terminus) acts at the catalytic site by activating the acceptor hydroxyl group, which would 24 
subsequently perform a nucleophilic attack on the C1 of the donor substrate (Lairson et al., 25 
2008). 26 
Candidate aspartate residues exist in GTF and it is possible to predict their location in the 27 
active site of this protein based on the 3D-structural model shown in Figure 4. Three 28 
aspartates (D143, D198 and D200) are coincident with those conserved and proposed in 29 
other glycosyltransferases from the GT-2 family, including glycosyltransferase SpsA of B. 30 
subtilis. The fourth aspartate (D306) is not a good candidate to be part of the active site 31 
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according to the current models and one alternative could be that at D295, though this 1 
should be evaluated by substrate docking experiments and site directed mutagenesis.  2 
4. Production, purification and analysis of EPS 3 
4.1 Methods of production 4 
Most LAB species show low yields of polysaccharide production which is the main reason 5 
for their lack of commercial exploitation. Generally (with a few exceptions) the yield of 6 
production is under 1 g L-1 for HoPS, when culture conditions are not optimized, and even 7 
less for the majority of the HePS. Van der Meulen et al. (2007) reported the EPS production 8 
by 10 LAB strains isolated from dairy and cereal products. Nine out of ten produced glucans 9 
in amounts from 0.8 to 1.7 g L-1. The only HePS producer was Lb. curvatus, which 10 
synthesized the EPS to levels of 22 mg L-1. Mozzi et al. (2006) reported that 31 HePS 11 
producers screened from 201 LAB strains (including thermophilic and mesophilic species) 12 
synthesized from 10 to 166 mg L-1. Only seven of them produced > 100 mg L-1.  13 
Efforts have been made to improve yields of EPS production by LAB resulting in a variety of 14 
methods well detailed in the literature. All of them focus on parameters that have a strong 15 
influence on the production of HoPS and HePS. As a general rule the amount and 16 
composition of the EPS produced by LAB is strongly influenced by the culture and 17 
fermentation conditions such as pH, temperature and medium composition (Dueñas et al., 18 
2003). 19 
The production of α-glucans by LAB can be obtained in the presence of sucrose, after 20 
optimization of sucrose concentration in the growth medium and the time of incubation. 21 
The depletion of the sucrose source would cause the arrest of the enzymatic reaction of the 22 
dextransucrases. It has been reported that high producers of dextran are primarily 23 
Leuconostoc strains, but many other strains of LAB are able to produce this bacterial 24 
polysaccharide (Sarwat et al., 2008). The importance of improving its production is related 25 
to the industrial applications in the food, pharmaceutical and chemical industries as 26 
adjuvant, emulsifier, carrier and stabilizer (Goulas et al., 2004). Lc. mesenteroides CMG713 27 
produces the highest concentration of dextran after 20 hours of incubation at 30°C in the 28 
presence of 15% sucrose at pH 7.0, with an EPS yield of 6 g L-1 (Sarwat et al., 2008). Recently, 29 
Capek et al. (2011) reported an exceptionally high production of this HoPS (50 g L-1) by Lc. 30 
garlicum PR. 31 
On the contrary, β-glucan production is very tedious, because of the low yield obtained. 32 
Therefore, it demands new strategies to improve synthesis apart from the optimization of 33 
growth parameters. For production of the 2-substituted (1,3) β-glucan heterologous gene 34 
expression has been tested. A plasmid, pNGTF, was constructed in order to express the P. 35 
parvulus gtf in L. lactis NZ9000. This plasmid allows inducible expression of the gtf gene from 36 
the nisA gene promoter by the addition of nisin to the growth medium (Werning et al., 37 
2008). The EPS released to the medium by NZ9000[pNGTF] was quantified and purified. 38 
The expression of GTF glycosyltransferase by NZ9000[pNGTF] yielded levels of purified 39 
EPS of 300 mg L-1 , when the bacteria was grown in batch conditions (Werning et al., 2008). 40 
The structural characterization of the purified EPS confirmed that the recombinant strain 41 
synthesizes and secretes the same 2-substituted (1,3)-β-D-glucan as P. parvulus 2.6 (Werning 42 
et al., 2008). The synthesis of the EPS was still not very high, but it could probably be 43 
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improved by optimizing growth conditions of the producing recombinant strain in 1 
continuous culture in a chemostat at controlled pH. 2 
With regard to HePS, their production has been improved in the native isolates by 3 
optimizing growth conditions and media composition. As an example, Vijayendra and Babu 4 
(2008) optimized the EPS production by Leuconostoc sp. CFR-2181, a strain isolated from 5 
dahi, an Indian traditional fermented dairy product, in a simple, low cost semisynthetic 6 
medium. Maximum biomass and HePS production was observed when sucrose was used as 7 
carbon source and a yield of 30 g L-1 of the biopolymer was obtained, although the 8 
concentration was estimated by dry weight and purity of the HePS was not assayed. As an 9 
alternative, to improve production of HePS, the eps clusters of various LAB have been 10 
overexpressed, mainly in L. lactis, by construction of recombinant strains carrying the genes 11 
in multicopy plasmids (e.g. the HePS of S. thermophilus Sfi39). In addition, metabolic 12 
engineering of L. lactis has been used to redirect carbon distribution between glycolysis and 13 
sugar nucleotide biosynthesis, with the aim of increasing intracellular levels of UDP-14 
glucose, UDP-galactose and UDP-rhamnose, the substrates of the glycosyltransferases 15 
encoded by plasmid pNZ4000 and involved in HePS biosynthesis in the NIZO B40 strain 16 
(Boels et al., 2002). 17 
The importance that EPS has gained in the food industries has been responsible for the 18 
development of other strategies to improve the total amount produced. Some good 19 
examples are their in situ production in food matrices and their in vitro production by use of 20 
immobilized enzymes. 21 
LAB can produce a large variety EPS during elaboration of dairy products. Since the use of 22 
LAB is historically considered safe (GRAS microorganisms), production in situ of novel 23 
functional EPS means that toxicological testing will be reduced, or not required, and the 24 
products can be quickly brought to the market (De Vuyst et al, 1999). 25 
Yogurt is a well-known dairy product derived from milk fermentation by cultures 26 
producing EPS (e.g. Lb. delbrueckii ssp. bulgaricus and S. thermophilus produce, respectively, 27 
60-150 mg L-1 and 30-890 mg L-1 of HePS) (Marshall and Rawson, 1999). The use of EPS-28 
producing starter cultures for yogurt elaboration is increasing, because these biopolymers 29 
improve water retention and texture and confer thickness without altering the organoleptic 30 
characteristics of the final product. Thus, there is no need to add stabilizers, many of which 31 
are prohibited in a wide range of countries. Although the role of pure EPS has not been 32 
studied, authors agree that the key points of improving the texture are the conformation of 33 
the EPS and their interactions with casein. (Badel et al., 2011).  34 
In the cheese making process strains such as Lb. delbrueckii ssp. bulgaricus, Lb. helveticus and 35 
Lb. casei, produce HePS. These polysaccharides, as occurs in yogurt, help to improve the 36 
rheological properties of the cheese. Their role in cheese elaboration depends on associations 37 
with other strains and also on the presence or absence of charges in the EPS produced. 38 
(Badel et al., 2011). 39 
Furthermore, there are other examples of in situ EPS production, such as kefir. This is a very 40 
important beverage in Eastern European countries. It is a fermented milk product produced 41 
by a population of different species of bacteria and yeasts. Several functional properties of 42 
kefir, such as is ability to modulate immune responses, to diminish allergic reactions and to 43 
inhibit tumour growth has been postulated for this beverage (Liu et al., 2002). LAB produce 44 
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lactic acid and yeast synthesize ethanol, which is used by Lb. kefiranofaciens to produce 1 
kefiran, a polysaccharide resistant to enzymatic degradation. Kefiran is a natural 2 
biopolymer that could be used as a thickener in fermented products. 3 
Finally, the use of enzymes for the in vitro synthesis of polysaccharides is showing promise. 4 
Immobilized enzymes are preferred as this allows the recovery and reuse of the enzyme, 5 
and may improve the properties of the enzyme such as stability, activity, specificity and 6 
selectivity (Mateo et al. 2007). The technique is used for production of 7 
isomaltooligosaccharides by immobilized dextransucrase. Isomaltooligosaccharides are 8 
oligosaccharides with prebiotic activity that can be produced either by acceptor reactions of 9 
dextransucrase or hydrolysis of dextran by dextranase. In the case of dextransucrase, it can 10 
also produce leucrose (a disaccharide used as sweetener). Other uses are also currently 11 
being developed e.g. immobilization of  β-galactosidase to produce galactooligosaccharides. 12 
Concerning immobilization technology, the alginate encapsulation method has the best 13 
performance, rendering yields of up to 90% (Tanriseven & Dogan, 2002). Dextranase has 14 
been immobilized on various supports including glutaraldehyde-activated chitosan, porous 15 
glass, bentonite and the commercially available matrix, Eupergit C, with high yield (90%) 16 
(Aslan & Tanriseven, 2007). Dextransucrase and dextranase share the optimum pH (pH 5.4) 17 
which facilitates their combined use. However, few studies using co-immobilization of 18 
dextransucrase and dextranase are yet available (Frank et al. 2008; Olcer & Tanriseven, 19 
2010).  20 
4.2 Methods of purification and characterization of EPS 21 
Purification is the physical separation of a chemical substance of interest from 22 
contaminating substances. In the case of EPS purification from bacterial culture 23 
supernatants means elimination of producer microorganisms and their secreted metabolites 24 
as well as components of the growth media. Ruas-Madiedo et al. (2005) extensively 25 
reviewed this subject, thus we shall present here only an overview of the more usual 26 
procedures, with a more detailed description of methods related to the determination of EPS 27 
structure. 28 
The first step of purification of EPS depends on the bacterial growth medium utilized for its 29 
production. In complex media or in food matrix, such as milk, the first requirement is the 30 
elimination of proteins. For their removal a precipitation with TCA as well as treatment with 31 
proteases are the most commonly used methods. Then, the supernatant as well as the 32 
supernatant of bacterial cultures grown in defined media are usually subjected to one or 33 
more cycles of precipitation with either ethanol or acetone. The biopolymers present in the 34 
supernatants, if they are soluble, are dissolved in water, and then dialysed to remove the 35 
low molecular weight contaminants, in general a membrane with a cut-off of MWCO 12-36 
14.000 Da is used.  37 
After lyophilisation of the samples, the EPS is often further purified using a 38 
chromatographic technique. The parameters involved in the choice of the appropriate 39 
chromatography are: charge, solubility and molecular weight of the ESP. Size-exclusion 40 
chromatography (SEC) is a chromatographic method in which molecules in solution are 41 
separated by their size, not by molecular weight. It is usually applied to large molecules or 42 
macromolecular complexes. Another example is ion-exchange chromatography, whicht 43 
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allows the separation of ions and polar molecules based on their charge. In general the 1 
procedure involves passing a mixture dissolved in a mobile phase through a stationary 2 
phase. For high molecular weight polysaccharides, such as the 2-substituted-(1-3)-β-glucan, 3 
SEC is the most suitable method, because the charge of the EPS is zero. In this case, dried 4 
EPS are dissolved in 0.3 M NaOH (to eliminate extra contaminants and to improve the 5 
solubility of the EPS) and centrifuged to eliminate insoluble material. The supernatant is 6 
loaded into a column of Sepharose CL-6B equilibrated with NaOH, which is also used as 7 
eluent. Fractions are collected, and monitored for carbohydrate content by the phenol-8 
sulphuric method (DuBois et al., 1956).  9 
Polysaccharides are polydisperse polymers, and consequently only an apparent average 10 
molecular weight (Mw) can be determined. To this end, the average Mw can be estimated 11 
after SEC fractionation. A calibration curve is performed by fractionation of standards 12 
(Dextran Blue, T70, T10, and vitamin B12) and used for the determination of the Mw. As 13 
alternative, high-performance size-exclusion chromatography (HPSEC) equipped with 14 
multi-angle laser-light scattering (MALLS) and refractive index (RI) detectors can be used to 15 
determine weight-average molecular weight (Mw) and z-average radius of gyration (Rz) of 16 
the EPS. 17 
To determine the monosaccharide composition of the EPS, the analysis of neutral sugars is 18 
performed by polysaccharide hydrolysis with 3M TFA. The resulting monosaccharides are 19 
converted into their corresponding alditol acetates by reduction with NaBH4 and 20 
subsequent acetylation (Laine et al., 1972). Identification and quantification is performed by 21 
gas-liquid chromatography (GLC) using a HP5 fused silica column, with a temperature 22 
program and a flame ionization detector. With this technique the chromatogram shows only 23 
one peak per each monosaccharide, leading to an easy identification of the monosaccharide 24 
composition. However, if the polysaccharide contains uronic acid(s) it must be subjected to 25 
methanolysis after the hydrolysis. An O-methyl glycoside is formed, the acid function is 26 
transformed into an ester group and the sugar derivative can then be acetylated and 27 
analyzed by GLC. 28 
To determine the type of bond between each residue present in the EPS molecule a 29 
methylation analysis is usually performed. The polysaccharides are methylated according to 30 
the method of Ciucanu and Kerek (1984). The partially methylated polysaccharides are 31 
hydrolyzed with 3M TFA and the products are reduced with NaBD4, acetylated and 32 
analyzed by gas chromatography/mass spectroscopy (GC-MS) (Leal et al., 2008). Each peak 33 
of the chromatogram is identified by the retention time and mass spectra parameters. The 34 
quantification is associated to the peaks area.  35 
To resolve the 3D-structure of an EPS molecule, both the ring size (pyranose/furanose) of 36 
the monosaccharide residues and the relative orientations of the adjacent monosaccharides 37 
have to be determined. Nuclear magnetic resonance (NMR) is the technique most often used 38 
to study the conformation of the polysaccharides and allows elucidation of the type of 39 
glycosidic linkages and the structure of the repeating units that constitute the EPS molecules 40 
(review by Duus et al., 2000). Before NMR analysis, the purified EPS is dissolved in D2O so 41 
that exchangeable protons are replaced by deuterium (deuteration). This procedure is 42 
repeated several times and may involve intermediate lyophylisation steps. A 1H NMR 43 
spectrum of the EPS gives information about the number of monosaccharide present in the 44 
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repeating unit by counting the resonances in the anomeric region (4.4-5.5 ppm). The 1 
common hexoses are detected as well in 13C NMR spectra (95-110 ppm). If there are 2 
resonances just downfield of 1 ppm in the 1H NMR spectrum it is a sign of CH3-groups of 3 
e.g. a fucose or a rhamnose residue. Resonances close to 2 ppm reveal N-acetyl and/or O-4 
acetyl functionalities. From the splitting of the anomeric peaks in 1H spectra (JH1,H2) the 5 
anomeric configuration can be established; a J-coupling of ~4 Hz indicates the α-6 
configuration and a value of ~8 Hz indicates the β-form for common monosaccharides like 7 
D-glucopyranose and D-galactopyranose. The corresponding values of JC1,H1 are ~170-175 8 
Hz for the α-form and ~160-165 Hz for the β-form obtained from a coupled 13C NMR 9 
analysis. Since most polysaccharide NMR spectra show peak overlap in the ring region (δH  10 
3.13.33.53.73.94.14.34.54.74.95.1
  11 
(A) 12 
 13 
(B) 14 
Fig. 5. NMR analysis of the purified the 2-substituted (1,3)-β-D-glucan. 1H-NMR (A) and 15 
1H,1H-COSY (B) spectra are depicted 16 
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3.1-4.4), 2D-NMR techniques are often applied. The proton chemical shifts are linked to their 1 
respective carbon by a 1H,13C-HSQC NMR analysis or, when the resonances in the 13C 2 
dimension overlap too much, a 13C,1H-HETCOR NMR analysis is performed. To distinguish 3 
methylene protons (CH2) from methyl (CH3) and methine (CH), a multiplicity-edited 1H,13C-4 
HSQC analysis can be used. The protons in each spin system can be assigned using 1H,1H-5 
TOCSY and/or 1H,1H-DQF-COSY analysis, both techniques allow the magnetization to 6 
travel over bonds with the help of J-couplings and thereby connecting the protons. EPS 7 
contain protons and carbons, but sometimes also nitrogen and even phosphorus. Their 8 
respective chemicals shifts can be assigned and correlated to 1H using e.g. 1H,15N-HSQC and 9 
1H,31PTOCSY analysis. The exchangeable amide protons, measured in a H2O-D2O mixture, 10 
have J-couplings to the ring protons and can be assigned correctly in the ring by a 1H,1H-11 
TOCSY with water suppression. As an example, the uni- and bi-dimensional NMR analysis 12 
of the 2-substituted (1,3)-β-D-glucan is depicted in Figure 5. The 1D-NMR spectrum (Fig. 13 
5A) revealed several peaks in the region between 3.2 and 4.1 ppm and 2 peaks in the 14 
anomeric region characteristics of this type of polysaccharide. 2D-COSY analysis (Fig. 5B) 15 
showed couplings between anomeric protons and C2 protons (H1C/H2C, H1B/H2B y 16 
H1A/H2A) characteristic of the 2-substituted (1,3)-β-D-glucan. 17 
Finally, to determine the supramolecular structure and conformation of an EPS, atomic force 18 
microscopy (AFM) is currently used. It has been applied successfully to visualize a range of 19 
polysaccharides including curdlan (Ikeda & Shishido, 2005), and oat β-glucan (Wu et al., 20 
2006). The (1,3)-β-D-glucan helixes dissociate into random coils when the strength of the 21 
bonds keeping the helix together are decreased below a critical limit. The helix-coil 22 
transition is referred to as denaturation (Sletmoen & Stokke, 2008). Denaturation of (1,3)-β-23 
D-glucan triplexes occurs in alkaline solutions or in dimethyl sulfoxide. In alkaline solutions 24 
due to the ionization of the hydroxyl groups and the subsequent electrostatic repulsion 25 
between chains, a previous dissociation of the aggregates takes places and then, as the 26 
alkalinity increases, the helix structure is believed to denature to yield individual disordered 27 
single chains (Sletmoen & Stokke, 2008). 28 
5. Biotechnological applications of EPS from LAB 29 
5.1 Current applications of the EPS in the food industry 30 
High molecular weight polysaccharides are used as additives in the manufacture of a wide 31 
variety of food products, because they act as thickeners, stabilisers, viscosifiers, emulsifiers 32 
or gelling agents. Most of these polysaccharides are derived from plants (e.g. pectin, 33 
cellulose) and seaweeds (e.g. alginate, carrageenan) (Kleerebezem et al., 1999). In terms of 34 
applications in the food industry, microbial extracellular polysaccharides including HePS 35 
such as xanthan from the phytopathogenic bacterium Xanthomanas campestris and gellan 36 
from Sphingomonas paucimobilis, are also alternative sources of biothickners approved by the 37 
FDA for use as foods additives (Laws et al., 2001). Although these are prepared in reliable 38 
quantities, their physical properties might not suit all applications, given that there is also a 39 
demand for novel materials that can improve rheological characteristics and health 40 
promoting properties. On the other hand, the use of bacterial polysaccharides as food 41 
additives requires their production by non-pathogenic bacteria. In this sense, LAB have QPS 42 
(qualified presumption of safety) status and EPS produced by these bacteria can be 43 
considered as food-grade additives (Ruas-Madiedo et al., 2008). 44 
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LAB are routinely used in food preparations, not only due to their metabolic activities, but 1 
also due to their preservative effects such as: (i) acidification or production of hydrogen 2 
peroxide and (ii) the production of bacteriocins (e.g. nisin), which restrict icrobial 3 
contamination (Kuipers et al., 1998; Wood, 1997). In addition, EPS production by LAB has 4 
received considerable attention, since they provide thickening properties and contribute to 5 
improve the texture and mouth-feel of the resulting fermented milks or other dairy 6 
products. Moreover, certain EPS produced by LAB, have beneficial effects on human health 7 
such as cholesterol-lowering, immunomodulation and prebiotic effect, features that are 8 
discussed later. It is therefore considered an advantage to use these polymers as food 9 
additives rather than the gram-negative polymers, for which no health promoting abilities 10 
have been proposed (Ruas-Madiedo et al., 2008). 11 
EPS may act both as a texturizer, improving the rheology (viscosity and elasticity) of a final 12 
product, and as physical stabilizers by binding hydration water and interacting with other 13 
milk constituents (ions and proteins) thus limiting syneresis. These physical and rheological 14 
properties depend on features such as chemical composition, molecular size, charge, 15 
presence of side chains, rigidity of the molecules and 3D- structures of the EPS polymers. In 16 
addition to physical characteristics, the interactions between EPS and various components in 17 
food products contribute to the development of the final product. Nevertheless, many 18 
studies have shown that rheological properties of fermented milk products do not correlated 19 
well with the amount of EPS content (de Vuyst, et al., 2001; Duboc & Mollet, 2001; 20 
Folkenberg et al., 2006). 21 
Despite the above, EPS from LAB have not yet been exploited industrially as food additives 22 
and one of the main drawbacks to use these polymers for such purpose is the low 23 
production level compared with xanthan (de Vuyst & Degeest, 1999). Furthermore, low cost 24 
culture media and easy isolation procedures, both rendering high yields are essential for the 25 
application of EPS as food grade additives. For this reason, production in situ by LAB can be 26 
an alternative to the use of biopolymers from plants or non-GRAS bacteria. In particular, 27 
HePS producing LAB are used in the dairy industry, mostly belonging to the genera 28 
Streptococcus, Lactobacillus and Lactococcus to improve the texture and organoleptic 29 
properties of the product. Some examples of these are the production of fermented milks 30 
such as viili and langmjolk in Nordic countries as well as the production of kefir, yogurt and 31 
low fat cheese type mozzarella and Cheddar cheese (de Vuyst et al., 2001; Ricciardi & 32 
Clementi, 2000; Ruas-Madiedo et al., 2008). Another application in development for the 33 
bakery industry is the in situ production of glucans or fructans by the use of Lactobacillus or 34 
Weissella strains in sour dough manufacture (Tieking et al., 2003). 35 
The use of cereal-base substrates is considered as a promising alternative to fermented dairy 36 
products due to their high nutritional value and the presence of both soluble and insoluble 37 
dietary fiber (Angelov et al., 2005; Materson et al., 2005). In this sense, regarding the 38 
development of new functional foods, and their particular ability to produce 2-substituted 39 
(1,3)- β-glucans, P. parvulus 2.6 and Lb. diolivorans G77 have been studied as starter cultures 40 
in the preparation of oat-based fermented foods. It has been found that these bacteria can 41 
grow and produce the EPS in the oat-base substrate, improving the viscosity and texture of 42 
the fermented product (Martensson et al., 2003). In addition, analysis of the rheological 43 
properties of the β-glucan synthesized by P. parvulus 2.6 showed that it has potential utility 44 
as a biothickener (Velasco et al., 2009). Also, it has been reported that differences in the 45 
 
Food Additive 
 
18 
viscosity of two cultures of different strains of Pediococus parvulus were not attributable to 1 
differences in the primary structure or molecular mass of the β-glucan produced (Garai-2 
Ibabe et al., 2010). Other factors such as EPS conformation or interactions between EPS and 3 
growth media microstructure could also affect the rheological features. Thus, presumably in 4 
the near future, 2-substituted (1,3)- β-glucan-producing LAB will be the used for elaboration 5 
of non-dairy fermented food. Moreover, the β-glucan could be used as a food additive, due 6 
to its gelling properties. 7 
5.2 Potential applications of EPS for production of functional food 8 
5.2.1 Prebiotics 9 
The concept of prebiotic was originally defined as “non-digestible food ingredient that 10 
beneficially affects the host by selectively stimulating the growth and/or activity of one or a 11 
limited number of bacteria in the colon, and thus improves host health” (Gibson & 12 
Roberfroid, 1995). Nine years later, this definition was revised by Gibson et al. (2004) and 13 
redefined the concept of prebiotic as “a selectively fermented ingredient that allows specific 14 
changes, both in the composition and/or activity in the gastrointestinal microbiota that 15 
confers benefits upon host wellbeing and health”.  16 
The non-digestible oligosaccharides (NDO) are the prototypes of prebiotic saccharides. The 17 
oligosaccharides are compounds with lower molecular weight due to a lower degree of 18 
polymerization (DP). Although the IUB-IUPAC defined oligosaccharides as saccharides 19 
composed of 3 to 10 monosaccharide units, other sources define them as compounds with 3 20 
to 20 monosaccharide units. Since, there is not a standard definition, the use of “short-chain 21 
carbohydrates” as a term to include oligosaccharides and smaller polysaccharides seems to 22 
be more appropriate. The NDO are oligosaccharides with monosaccharide units, having a 23 
configuration that makes their osidic bonds non-digestible by the hydrolytic activity of the 24 
human digestive enzymes (Roberfroid & Slavin, 2000). They have a low calorific value, non-25 
cariogenicity, are associated with a lower risk of infections and diarrhoea, promote the 26 
growth of beneficial bacteria in the colon and an improvement of the immune system 27 
response (Mussatto & Mancilha, 2007). The ability of the gut microbiota to ferment 28 
oligosaccharides depends on a variety of factors including the degree of polymerization, 29 
type of sugar, the glycosidic linkage and the degree of branching, as well as the synergy 30 
between bacteria during fermentation, the relationship between substrate bacteria and 31 
fermentation products, the nature of the fermentations and the saccharolytic capacity of the 32 
bacteria (Voragen, 1998).  33 
The production of oligosaccharides in food started to be investigated in Japan, between 34 
1970-1975, and since then a number of these biopolymers have been identified (Table 1). The 35 
USA and Europe have recently become leaders in fructan, fructo-oligosaccharide (FOS) and 36 
inulin production. The reason is linked to their low cost production as well as the 37 
reproducibility of prebiotic effects in humans. Galacto-oligosaccharides (GOS) are also 38 
commercialized in these countries but not yet as widely used as fructans. (Rastall & Maitin, 39 
2002). 40 
The oligosaccharides have been widely used in foods, beverages and confectionery due to 41 
their properties as hygroscopicity, stabilization of active substances (involved in e.g. flavour 42 
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and colour), water activity, sweetness and bitterness. They can be obtained by three 1 
different ways: (i) extraction with hot water from roots (e.g. inulin) or seeds (e.g. soybean 2 
oligosaccharides), (ii) enzymatic synthesis from one or a mixture of disaccharides using 3 
osyl-transferases (e.g. fructooligosaccharides) or (iii) partial enzymatic hydrolysis of 4 
oligosaccharides (e.g. oligofructose) or polysaccharides (e.g. xylooligosaccharides) (Roberfroid 5 
& Slavin, 2000). 6 
Compound Molecular structure* Raw material Process 
Cyclodextrins (Glu)n Starch transglycosylation 
Fructooligosaccharides (Fru)n-Glu Sucrose transglycosylation 
Galactooligosaccharides (Gal)n-Glu Lactose transglycosylation 
Gentiooligosaccharides (Glu)n Starch 
Transglycosylation 
/hydrolysis 
Glycosylsucrose (Glu)n-Fru Sucrose transglycosylation 
Isomaltooligosaccharides (Glu)n Starch 
Transglycosylation 
/hydrolysis 
Isomaltulose (palatinose) (Glu-Fru)n Sucrose transglycosylation 
Lactosucrose Gal-Glu-Fru Lactose/Sucrose transglycosylation 
Lactulose Gal-Fru Lactose isomerization 
Maltooligosaccharides (Glu)n Starch hydrolysis 
Raffinose Gal-Glu-Fru Sucrose extraction 
Stachyose Gal-Gal-Glu-Fru Sucrose extraction 
Soybean 
oligosaccharides (Gal)n-Glu-Fru Starch extraction 
Xylooligosaccharides (Xyl)n Xylan hydrolysis 
Table 1. Non-digestible oligosaccharides. * Glu, glucose; Fru, fructose; Gal, galactose, Xyl, 7 
xylose 8 
Polysaccharides are often the main source of bioactive oligosaccharides and therefore new 9 
sources of them are continuously investigated. In this context, LAB have become a 10 
promising target due to its GRAS/QPS status. Currently, bioactive commercialized 11 
oligosaccharides are extracted from plants but not yet from LAB. However, the high 12 
diversity of LAB and their EPS offer new possibilities for detection and production of 13 
bioactive oligosaccharides. To obtain oligosaccharides, the post-synthetic engineering 14 
strategies consist in enzymatic or chemical actions involving two types of enzymes, 15 
glycosyl-hydrolases (EC 3.2.1.y) and polysaccharide lyases (EC 4.2.2.y). A strategy to make 16 
the action of the enzyme specific is to grow the EPS-producing bacteria on plates with their 17 
own polysaccharide as a carbon source so that in order to survive, they themselves secrete 18 
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EPS degrading enzymes. After detection and purification, a specific enzyme for catalysis of 1 
the polysaccharide is obtained (Badel et al., 2011). 2 
5.2.2 Immunomodulators 3 
An immunomodulator is a substance which has an effect on the immune system. This 4 
system can be regulated in different ways by the use of immunosuppressors or 5 
immunostimulants to inhibit or to induce the immune responds. In particular, their use, 6 
included as additives in food, could be useful to combat infections, to prevent digestive tract 7 
cancers or to treat sicknesses due to immunodeficiency, such as inflammatory bowel 8 
diseases (Crohn's disease and ulcerative colitis). One strategy to modulate the immune 9 
system is the modulation of cytokine expression through the use of herbal medicines. The 10 
immunomodulators alter the activity of immune function through the dynamic regulation of 11 
informational molecules such as cytokines. (Spelman et al., 2006). 12 
The mechanism involved in the immunomodulation can be explained by the interaction of 13 
the immunomodulators to their receptor in the membrane of an immune system cell. This 14 
interaction activates an internal cascade of phosphotranfer of proteins mediated by kinases 15 
and related to a specific pathway. As a consequence, a change of binding affinity of 16 
transcriptional regulators for their operators takes place, which results in activation or 17 
repression of gene expression (Figure 6). 18 
 19 
Fig. 6. stimulation and/or inhibition mediated by immunomodulators 20 
Neither HoPS nor HePS produced by LAB have been used to elaborate functional food, nor 21 
directly tested as immunomodulators. However, most of the LAB used as probiotics 22 
(according to FAO/WHO, "live microorganisms which when administered in adequate 23 
amounts confer a health benefit on the host") for elaboration of functional food, have 24 
immunomodulatory properties (Foligne et al, 2007), and produce EPS. However, their 25 
ability to immunomodulate is strain specific and can not yet be directly connected to the 26 
EPS. In addition, current knowledge (see below) indicates that the nature and structure of 27 
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some of these biopolymers synthesized by LAB have the potential to be used as 1 
immunomodulating food additives.  2 
β-glucans are known as “biological response modifiers" (Wasser 2011), due to their ability to 3 
activate the immune system. β-glucans are integral cell wall components of a variety of 4 
fungi, plants and bacteria. In the early 40’s Pillemer and Ecker (1941) described the effect of 5 
a crude yeast cell wall, called Zymosan, and described that this extract was able to activate 6 
the non-specific innate immunity. Only in the 80’s Czop and Austin (1985) described the 7 
action of Zymosan that involved its binding to a β-1-3-glucan specific receptor, latter on 8 
identify and named Dectin-1 (Brown et al., 2001), found in the cell membrane of 9 
macrophages, which activates an internal cascade of events. 10 
The immunomodulating function of the β-glucans is related to their structure; in fact 11 
different polysaccharides are able to interact with specific receptors, due to their 3D-12 
structure. It have been recently demonstrated that β-glucans with a linear backbone 13 
containing 1-3 linkage (e. g. Zymosan) have the ability to activate several receptors: Dectin-14 
1, complement receptor 3 (CR3), scavenger receptors class A and class B, and Toll-like 15 
receptors (TLRs) 2 and 6 (Chlubnova et al., 2011). The interaction with these receptors 16 
triggers a cascade of internal effects, including production of cytokines (TNF-α, IL-6 and IL-17 
10). 18 
Also branched 6-substituted (1-3)- β-glucans isolated from mushroom, Candida albicans and 19 
Pneumocystis carinii, show high affinity for Dectin-1 (Palma et al., 2006) and for TLR-2 and 20 
TLR-4 receptors in elicitation of immune response (Chlubnova et al. 2011). Mushroom, 21 
especially Basidiomycetes, are a source of β-glucans with a high biological activity. They 22 
mostly have a 1-3 linkage in the main chain, and sometime an additional 1-6 branch point. 23 
This branching point increase their antitumoral and immunomodulating effects (Barreto-24 
Bergter & Gorin, 1983). It is well established that the structural composition offers a higher 25 
capacity for carrying biological information, because they have a greater potential for 26 
structural variability, specially related to the triple-helical tertiary conformation (Yanaki et 27 
al., 1983). A good example of a preventive effect is given by a Japanese study on their 28 
popular edible and medicinal mushroom Hypsizygus marmoreus (Ikekawa, 2001). In this 29 
study mice were divided into two groups: untreated and treated with a diet containing 5% 30 
of the dried fruiting body of H. marmoreus. All mice were injected with a strong carcinogen, 31 
methyl-cholanthrene, and carcinogenesis was investigated. The results obtained allowed to 32 
the authors to conclude that the mechanism of prevention and inhibition of carcinogenesis 33 
was due to immunopotentiation (Ikekawa, 2001). Therefore, (1,3) β-glucan produced by LAB 34 
and their producing strains have potential as immunomodulators. 35 
In this line, it has been shown that 2-substituted (1,3) β-glucan producer LAB belonging to 36 
the Lactobacillus and Pediococcus genera are able to immunomodulate macrophages in vitro 37 
(Fernández de Palencia et al., 2009; Garai-Ibabe et al., 2010). Moreover, treatment of the 38 
macrophages with the purified biopolymer resulted in an increase of secretion of the anti-39 
inflammatory IL-10 cytokine (Fernández de Palencia et al., unpublished results). In 40 
addition, four β-glucan-producing LAB strains have been tested for their survival under 41 
gastrointestinal stress (Fernánded de Palencia et al., 2009; Garai-Ibabe et al., 2010) , using 42 
an in vitro model that simulates conditions of human gut (Fernández de Palencia et al., 43 
2008). Among them, P. parvulus 2.6 and Lb. suebicus CUPV221 showed significant 44 
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resistance to digestve tract gut conditions. Furthermore, the presence of the EPS conferred 1 
to the producing strains increased capability to adhere to Caco-2 human epithelial 2 
intestinal cells (Garai-Ibabe et al., 2010; Fernández de Palencia et al., 2009). Thus, the use 3 
of the 2-substituted (1,3) β-glucan as an additive, or produced in situ, in fermented food or 4 
in the gut has potential as an immunomodulator to alleviate inflammatory bowel diseases. 5 
In addition, human consumption of oat-based food prepared with P. parvulus 2.6 resulted 6 
in a decrease of serum cholesterol levels, boosting the effect previously demonstrated for 7 
(1,3)-β-D-glucans in oat (Martensson et al., 2005). Finally, the production of yogurt and 8 
various beverages with 2-substituted β-D-glucan-producer LAB indicate advantageous 9 
techno-functional properties of these strains (Elizaquível et al., 2011). Therefore, LAB 10 
producing this EPS have potential as probiotic strains useful for the manufacture of 11 
functional foods. 12 
Dextrans have been also investigated as immunomodulators. Previous studies on dextran-70 13 
justified its beneficial effect in the prevention of acute respiratory distress syndrome after 14 
trauma and sepsis as well as pancreatitis (Modig, 1988). Recently, It was reported that 15 
dextran-70 reduced the leukocyte-endothelium interaction. In a clinical trial forty patients 16 
who were undergoing coronary bypass surgery were divided into 2 groups of 20. In Group 17 
A a dextran-70 infusion was administrated at a concentration of 7.5 ml kg-1 before the 18 
surgery, and 12.5 ml kg-1 after the cardiopulmonary bypass. Group B was the control and 19 
received a gelatin infusion at the same concentration. Several parameters were measured 20 
including determination of IL 8, IL 10 and troponin-I levels. The conclusion was that this α-21 
glucan was able to reduce the systemic inflammatory response and the release of the cardiac 22 
troponin-I after cardiac operation (Gombocz et al., 2007). 23 
Another α-glucan from the edible mushroom Tricholoma matsutake has been investigated, 24 
and reported to have excellent biological activities; exerting modulating effects on the 25 
immune competence of mice and rats. In this study, a sodium hydroxide extract of the 26 
mushroom was defatted followed by fractionation with a combination of ion exchange 27 
chromatography and gel filtration to identify the active component. A single-peak fraction 28 
(MPG-1) was obtained after reverse-phase chromatography. MPG-1 was a glycoprotein with 29 
molecular mass of 360 kDa, and contained about 90% glucose. NMR and methylation 30 
analysis revealed that the α-1,4-linkage was the predominant glucan linkage with α-1,6- and 31 
α-1,2-branching in the minority. It was demonstrated that the mycelium preparation is 32 
effective in improving immunological functions in stressed individuals. In an in vitro model 33 
the compound formed a complex with the active form of TGF-β1. These results indicate that 34 
the mycelium contains a novel α-glucan-protein complex with immunomodulatory effect 35 
(Hoshi et al., 2005). 36 
Therefore, the high production of α-glucans by LAB and the immunomodulatory properties 37 
of these bio-molecules as described above, predict that in the near future studies will be 38 
performed to evaluate the beneficial properties of these EPS, with the aim to use them as 39 
food additives. 40 
Finally, the low yield of HePS produced by LAB and their complex biosynthetic pathway, 41 
suggests that in the short term they are not very good candidates as food additives, 42 
although it is expected that the immunomodulatory properties of the producing strains will 43 
be further investigated. 44 
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6. Conclusion 1 
Currently it is clear that diversification of functional foods, which have been scientifically 2 
validated as having beneficial properties, will increase in the near future, and the EPS 3 
synthesized by LAB could have a place in the market as an ingredient of this type of food. 4 
To this end, EPS can be synthesized in situ by their producing strains or can be used in 5 
isolated form as a food additive. Their chances of reaching the marketplace will be 6 
improved by the discovery and utilization of new EPS-producing strains isolated from 7 
sources other than dairy products. The discovery and characterization of new EPS-8 
producers isolated from food (e.g. processed meat products) and beverages (e.g. wine and 9 
cider) will increase the variety of EPS and the use of their producing strains for the 10 
elaboration of novel solid and liquid functional food. For example, Lc. mesenteroides Lb. 11 
plantarum and Lb. sakei strains have been isolated from Spanish sausages. They produce 12 
highly homogeneous, α-glucan HoPS synthesised by a dextransucrase, and are able to 13 
immunomodulate macrophages (Nacher et al., unpublished results). Microorganisms that 14 
are native to the human gut and produce EPS (or could be engineered to produce EPS) 15 
would also be of great interest as their chances of survival in the gut environment would be 16 
much higher than other microbes. It has been shown that microorganisms that produce 2-17 
substituted-(1,3)-β-glucan are able to adhere to human gut epithelial cells. Such organisms 18 
would presumable be able to colonise the gut and compete effectively with pathogens, at the 19 
same time as producing a beneficial immunomodulation. 20 
However, the use of EPS producing LAB strains will require a thorough scientific evaluation 21 
both in vitro and in vivo. It has to be stated that currently most of the general claims for 22 
components of functional food, (though this does not apply to oat β-glucans and their blood 23 
LDL-cholesterol lowering properties), have not been approved for use after evaluation by 24 
the European Food Safety Authority (EFSA, http://www.efsa.europa.eu). The main reason 25 
for rejection of probiotic bacteria has been the lack of enough characterization of the bacteria 26 
(determination of the nucleotide sequence of their entire genome is advisable), and/or 27 
insufficient scientific evidence to correlate the use of the bacteria with health benefits (Lb. 28 
delbrueckii subsp. bulgaricus AY/CSL and S. thermophilus 9Y/CSL and beneficial modulation 29 
of the gut microbiota). Therefore, each particular strain has to be subjected to evaluation, 30 
although its EPS has been already experimentally validated. The evaluation should be 31 
performed, first in vitro, then in animal models and finally in human trails. In addition, due 32 
to the rules of the EFSA the used of genetically modified organisms (GMO) is restricted 33 
(although they are not totally forbidden). Moreover, the opinion of consumers in Europe 34 
and USA regarding the use of GMO in food is not favourable. Consequently, well-35 
characterized (preferably GRAS) EPS-producers from natural ecological environments are 36 
the best candidates for use in functional food. 37 
However, if the EPS are going to be used as food additives, after purification, then there is 38 
no restriction concerning the use of a GMO producing strain. The use of GMO able to 39 
produce high levels of EPS or newly designed biopolymers is still very limited, and the 40 
production levels of most EPS are not very high. Therefore, provided that enzymes, and 41 
hence the genes, involved in their biosynthetic pathways are known, the future 42 
improvement of EPS production, will be by DNA recombinant technology and metabolic 43 
engineering to generate GMO EPS-producing LAB, that will be used for production of the 44 
biopolymers in large-scale fermenters. Moreover, genetic engineering could be used to alter 45 
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substrate specificity of the EPS biosynthetic enzymes to generate new polysaccharides and 1 
oligosaccharides with improved prebiotic properties. In the case of the glycosyltransferases, 2 
which synthesize HoPS this strategy could result in the synthesis of not only new HoPS, but 3 
also new HePS. Finally, the requirement of only one protein for the synthesis opens the 4 
window for production of new biopolymers by immobilized enzymes. 5 
Overall, there should be a rapid expansion in the development of novel LAB probiotic 6 
organisms and their prebiotic EPS products. However, their ultimate success in the market 7 
place will require a rigorous scientific evaluation. 8 
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